| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 70,995 | 66,793 | 66,431 | 62,420 | | Cost of Revenue | 41,537 | 40,071 | 40,908 | 38,809 | | | Gross Profit | 29,458 | 26,722 | 25,523 | 23,611 | | | Operating Expenses | | Research Development | 1,265 | 1,323 | 1,261 | 983 | | Selling General and Administrative | 17,829 | 17,903 | 17,090 | 16,029 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 10,364 | 7,496 | 7,172 | 6,599 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8 | 12 | 24 | 38 | | Earnings Before Interest And Taxes | 10,364 | 7,508 | 7,196 | 6,637 | | Interest Expense | 387 | 626 | 588 | 674 | | Income Before Tax | 9,985 | 6,882 | 6,608 | 5,963 | | Income Tax Expense | 3,817 | 2,603 | 2,425 | 2,189 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,168 | 4,279 | 4,183 | 3,774 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,168 | 4,279 | 4,183 | 3,774 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,168 | $4,279 | $4,183 | $3,774 |
|
0.02% Nasdaq 
0.33%
Income Statement
